NCT06418646

Brief Summary

The progressive loss of physical functioning resulting from ALS leads also to high psychosocial burden for those affected, and organizational challenges related to medical care and aids. A multidimensional and -professional care is advised in order to meet the complex requirements of this disease. In Germany, medical care structures may not fulfil these high requirements, since non-medical services such as psychological support or social counselling are not regularly included in care procedures for ALS patients. Specialised palliative care is not a standard and still commonly restricted to the last weeks of life. Additionally, it is well known that caregivers of ALS patients are highly burdened, but there is a lack of support services for them. By means of a cross-sectional, multicentre survey, we aim to investigate patients' and caregivers' perception of medical care for ALS, provided in Germany - with particular regard to psychosocial and palliative aspects. The extent to which physical, psychological, social, spiritual, practical and informational needs are subjectively met will be assessed and correlations with mental wellbeing, subjective quality of life, attitudes towards life-sustaining measures and physician-assisted suicide, as well as caregiver burden will be examined. Currently, study planning (questionnaires and ethical approval) is already completed and recruitment was started. The study aims to recruit 500 participants from nationwide ALS-centres. Cooperating ALS-centres will be recruited via the German Network for Motoneuron Diseases (MND-Net), of which our centre is a member. It is intended to provide data-based starting points on how care of ALS patients and their caregivers can be improved in Germany, in line with their needs.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

May 8, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 17, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

2.4 years

First QC Date

May 8, 2024

Last Update Submit

May 13, 2024

Conditions

Keywords

palliative carecaregiver burdenmultidimensional care

Outcome Measures

Primary Outcomes (1)

  • patients' satisfaction with professional care

    patients' satisfaction with professional care for potential symptoms in the six domains physical, psychological, social, spiritual, practical and informational

    baseline

Secondary Outcomes (4)

  • subjective quality of life

    baseline

  • mental wellbeing

    baseline

  • caregiver burden

    baseline

  • attitudes towards life-sustaining measures and assisted suicide

    baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with Amyotrophic Lateral Sclerosis and their caregivers

You may qualify if:

  • patients with at least "possible ALS" according to El-Escorial-criteria
  • at least 18 years old
  • no impairments of behaviour or mental performance relevant to everyday life that limits the ability to make judgments or give consent (e.g. as part of a comorbid FTD)

You may not qualify if:

  • impairments of behaviour or mental performance relevant to everyday life that limits the ability to make judgments or give consent (e.g. as part of a comorbid FTD)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Carl Gustav Carus at Technische Universität Dresden

Dresden, Saxony, 01307, Germany

RECRUITING

Related Publications (1)

  • Linse K, Weber C, Reilich P, Schoberl F, Boentert M, Petri S, Rodiger A, Posa A, Otto M, Wolf J, Zeller D, Brunkhorst R, Koch J, Hermann A, Grosskreutz J, Schroter C, Gross M, Lingor P, Machetanz G, Semmler L, Dorst J, Lule D, Ludolph A, Meyer T, Maier A, Metelmann M, Regensburger M, Winkler J, Schrank B, Kohl Z, Hagenacker T, Brakemeier S, Weyen U, Weiler M, Lorenzl S, Bublitz S, Weydt P, Grehl T, Kotterba S, Lapp HS, Freigang M, Vidovic M, Aust E, Gunther R. Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre study. Neurol Res Pract. 2024 Jul 4;6(1):34. doi: 10.1186/s42466-024-00328-1.

Related Links

MeSH Terms

Conditions

Amyotrophic Lateral SclerosisCaregiver Burden

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesNeuromuscular DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • René Günther, PD Dr.

    University Hospital Carl Gustav Carus at Technische Universität Dresden

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katharina Linse, Dr.

CONTACT

René Günther, PD Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2024

First Posted

May 17, 2024

Study Start

August 1, 2022

Primary Completion

December 31, 2024

Study Completion

June 30, 2025

Last Updated

May 17, 2024

Record last verified: 2024-05

Locations